Abstract Submission Guidelines

Abstract Submission Guidelines:

Abstract text Word count: 700 (inclusive of title and abstract text)
Font: Arial; Font Size: 11

Structure is permitted, but not required: Introduction, Methods, Results, Conclusions

  • Multiple paragraphs are permitted
  • Do not use bold or underline formatting; italics are permitted
  • Use numerals to indicate numbers unless they are at the beginning of a sentence
  • References are to be cited within the text, not as footnotes
  • Figures and Tables are not included in the text count and must be uploaded as separate files. See below for file guidelines
  • Please ensure any symbols are viewable and accurate after entering your abstract



  • Should objectively describe the study
  • Should be in sentence case
  • Should use generic rather than proprietary drug names
  • Should not allude to a result or conclusion of the study


Abstract type

  • Abstract
  • All types of clinic-based and laboratory-based research projects relating lymphoma are eligible for submission. If a clinical trial, indicate if the trial has been registered, the registry, and the registration number.
  • Figures and tables
    • Figures and tables must be submitted as images and thus do not count towards the character count limit. Files should be shared as jpeg, png or gif. PDF and TIF files are not permitted.


Abstract submissions will close on Friday, March 17, 2023

Abstracts will be announced on Friday, March 31, 2023

Abstracts should be submitted to iucls@bioascend.com